| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |